NCT05312710 2026-01-16Safety and Efficacy of APG-157 in Head and Neck CancerAveta Biomics, Inc.Phase 2 Active not recruiting24 enrolled
NCT03254927 2023-04-03A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaCelldex TherapeuticsPhase 2 Terminated30 enrolled 17 charts